SML3029

HG-9-91-01

>95% (HPLC)

• Synonym(e): 1-(2,4-Dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-(6-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)urea, HG 9-91-01, N-(2,4-Dimethoxyphenyl)-N′-(2,6-dimethylphenyl)-N-[6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]urea
• Empirische Formel (Hill-System): C₃₂H₃₇N₇O₃
• CAS-Nummer: 1456858-58-4
• Molekulargewicht: 567.68
• MDL-Nummer: MFCD28167714
• UNSPSC-Code: 12352200
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: >95% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 2 mg/mL, clear
• Lagertemp.: 2-8°C
• SMILES String: O=C(NC1=C(C)C=CC=C1C)N(C2=CC=C(OC)C=C2OC)C3=CC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=N3
• InChI: 1S/C32H37N7O3/c1-22-7-6-8-23(2)31(22)36-32(40)39(27-14-13-26(41-4)19-28(27)42-5)30-20-29(33-21-34-30)35-24-9-11-25(12-10-24)38-17-15-37(3)16-18-38/h6-14,19-21H,15-18H2,1-5H3,(H,36,40)(H,33,34,35)
• InChIKey: UYUHRKLITDJEHB-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

HG-9-91-01 is an ATP site-targeting WH-4-023 (KIN112) structural analog that inhibits salt-inducible kinases (SIKs) with improved potency (IC50 = 0.6/6.6/9.6 nM against SIK1/2/3) and selectivity, exhibiting significant inhibitory activity only against 4 kinases among a panel of 108 (% inhibition at 100 nM ∼85/EPHA2, 88/EPHA4, 91/Src, 88/YES1) and much reduced or little potency toward the others (by <67% inhibition at 100 nM), including AMPK-related kinases BTK, MARK and NUAK. HG-9-91-01 (500 nM) enhances LPS-induced IL-10 production, while suppresses proinflammatory cytokine secretion from murine marrow-derived macrophages & dendritic cells (BMDMs & BMDCs) as well as primary human macrophages in a CRTC3-dependent manner. A useful tool for studying SIKs-mediated cellular signaling events.

Potent and selective inhibitor against salt-inducible kinases SIK1, SIK2, and SIK3

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable